Top ▲

The IUPHAR/BPS Guide to PHARMACOLOGY complete ligand list

Click here for help
Includes therapeutic monoclonal antibodies.

A  B  C  D  E  F  G  I  L  M  N  O  P  Q  R  S  T  U  V  X  Y  Z 

Ligand name ID Synonyms
A Back to top
abagovomab 8265 ACA125, MEN-2234
abatacept Approved drug Immunopharmacology Ligand 6891 BMS-188667, CTLA4-IgG4m, Orencia®, RG-1046, RG-2077
abciximab Approved drug 6584 7E3 antibody, antiGPIIBIIIa, C7E3, ReoPro®
AbGn-168H Immunopharmacology Ligand 10013 AbGn-168, neihulizumab
abrezekimab Immunopharmacology Ligand 9806 CDP7766, UCB-4144, UCB4144, VR-942
abrilumab Immunopharmacology Ligand 11531 AMG 181, AMG-181, MEDI-7183, MEDI7183
adalimumab Approved drug Immunopharmacology Ligand 4860 D2E7, Humira®
aducanumab Approved drug 8325 aducanumab-avwa, Aduhelm®, BART, BIIB-037, BIIB037
aflibercept Approved drug 6786 AVE0005, Eylea®, VEGF Trap, Zaltrap®, ziv-aflibercept
AFM13 Immunopharmacology Ligand 10067 AFM 13, AFM-13
alefacept Approved drug Immunopharmacology Ligand 6787 Amevive®, BG 9273, BG 9712, BG-9273, BG-9712, Lfa3Tip
alemtuzumab Approved drug Immunopharmacology Ligand 6770 campath 1H, Campath®, campath-1H, Lemtrada®
alirocumab Approved drug 6744 Praluent®, REGN727, SAR-236553, SAR236553
ALT-803 Immunopharmacology Ligand 9615 IL-15 N72D:IL-15RαSu/Fc, IL-15SA, N-803
ALX148 11592
amatuximab 7750 MORAb-009
AMG820 Immunopharmacology Ligand 9106
amivantamab Approved drug 10505 amivantamab-vmjw, JNJ-61186372, JNJ-6372, JNJ61186372, Rybrevant®
anatumomab mafenatox Immunopharmacology Ligand 9947 5T4FabV13SEAD227A, ABR 214936, ABR-214936, ABR214936, pMB125, PNU 214936, PNU-214936, PNU214936, TTS-CD2
andecaliximab Immunopharmacology Ligand 9510 GS-5745, GS5745
anifrolumab Approved drug Immunopharmacology Ligand 8258 anifrolumab-fnia, MDX-1333, MEDI-546, Saphnelo®
anti-ILT7 antibody 9124
apitegromab 11180 SRK-015, SRK015
atezolizumab Approved drug Immunopharmacology Ligand 7990 MPDL3280A, Tecentriq®
atibuclimab Immunopharmacology Ligand 11326 IC14
avdoralimab Immunopharmacology Ligand 11345 anti-hC5aR-32F3A6 GL, IPH-5401, NN-8210, NNC-0215-0384
avelumab Approved drug Immunopharmacology Ligand 8735 Bavencio®, MSB-0010718C, MSB0010718C
 
B Back to top
bamlanivimab 11325 LY-3819253, LY-CoV555, LY3819253
bapineuzumab 6930 3D-6, AAB-001
basiliximab Approved drug Immunopharmacology Ligand 6879 CHI-621, L04AC02, SDZ-CHI-621, Simulect®
bavituximab 8002 Tarvacin ch3G4
begelomab Immunopharmacology Ligand 8691 Begendina&rg; (proprietary name), BT 5/9, SAND 26
belantamab mafodotin Approved drug Immunopharmacology Ligand 11117 belamaf, belantamab mafodotin-blmf, Blenrep®, GSK-2857916, GSK2857916
belatacept Approved drug Immunopharmacology Ligand 6892 BMS-224818, LEA29Y, Nulojix®
belimumab Approved drug Immunopharmacology Ligand 6887 Benlysta®, hBlySmAb-1.1, LimphoStat-B, lymphostat-B
bemarituzumab 11278 FPA-144, FPA144
benralizumab Approved drug Immunopharmacology Ligand 7674 BIW-8405, Fasenra®, KHK4563, MEDI-563
bermekimab 8089 MABp1, RA-18C3, Xilonix® (proposed trade name)
bevacizumab Approved drug 6771 Avastin®, rhuMAb-VEGF
bifikafusp alfa Immunopharmacology Ligand 9756 Darleukin, L19-IL2, L19IL2
BIIB059 Immunopharmacology Ligand 11122
bimagrumab 8086 BYM-338, BYM338
bimekizumab Immunopharmacology Ligand 9411 CA028_0496, CDP4940, gL7gH9, UCB-4940, UCB4940, Zu-G1
bintrafusp alfa 11376 M7824, MSB0011359C
blinatumomab Approved drug Immunopharmacology Ligand 7384 Blincyto®, bscCD19xCD3, MEDI-538, MT-103, MT103
bococizumab 7730 PF-04950615, RN-316, RN316
BPS-804 9202 BPS 804, BPS804
brazikumab Immunopharmacology Ligand 9293 AMG 139, AMG-139, MEDI2070
brentuximab vedotin Approved drug Immunopharmacology Ligand 6772 Adcetris®, anti-CD30 ADC SGN-35, SGN 35
briakinumab Immunopharmacology Ligand 9213 ABT-874, J-695, J695, Ozespa
brodalumab Approved drug Immunopharmacology Ligand 7540 AMG-827, AMG827, Kyntheum®, Lumicef®, Siliq®
brolucizumab Approved drug 8713 Beovu®, brolucizumab-dbll, ESBA-1008, ESBA1008, RTH258
brontictuzumab 11361 OMP-52M51, OMP52M51
BsAb (CD89-CD20) Immunopharmacology Ligand 9833
burosumab Approved drug 9292 burosumab-twza, Crysvita®, KRN-23, KRN23, N5KG1_C10_LH, UX-023, UX023
 
C Back to top
cabiralizumab Immunopharmacology Ligand 9107 BMS-986227, FPA-008, FPA008
camrelizumab Approved drug Immunopharmacology Ligand 9758 INCSHR1210, SHR-1210
canakinumab Approved drug Immunopharmacology Ligand 6773 ACZ 885, ACZ885, Ilaris®
caplacizumab Approved drug 9123 ALX-0081, anti-vWF Nanobody, Cablivi®, caplacizumab-yhdp
capromab Approved drug 6878 capromab pendetide, CYT-351, CYT-356, Indium In 111 capromab, ProstaScint®
carotuximab 9098 c-SN6j, TRC-105, TRC105
casirivimab Approved drug 11327 REGN-10933, Ronapreve® (imdevimab + casirivimab)
catumaxomab Approved drug 7385 L01XC09, Removab®
CDX-0159 11607
cemiplimab Approved drug Immunopharmacology Ligand 10090 cemiplimab-rwlc, Libtayo®, REGN-2810, REGN2810, SAR-439684, SAR439684
certolizumab pegol Approved drug Immunopharmacology Ligand 6774 CDP870, Cimzia®, PHA 738144
cetuximab Approved drug 6882 C225, Erbitux®, IMC-225, IMC-C225
CFZ533 Immunopharmacology Ligand 9802 CFZ-533, iscalimab (proposed INN), NVP-CFZ533, OM11-62MF
cilgavimab 11329 AZD1061, COV2-2130
CIS43 Antimalarial Ligand 11254
clazakizumab Immunopharmacology Ligand 9195 ALD-518, ALD518, BMS-945429
codrituzumab 8406 GC33, RG-7686, RG7686, RO-5137382, RO5137382
concizumab 11182 Anti-TFPI, mab2021, NN7415
COVA322 Immunopharmacology Ligand 10469
CR3022 11076
crenezumab 6934 MABT-5102A, Mabt5102A
crizanlizumab Approved drug 10550 Adakveo®, crizanlizumab-tmca, hSel001, SEG101
crotedumab 9614 REGN-1193, REGN1193
cusatuzumab Immunopharmacology Ligand 9778 ARGX-110, ARGX110, clone 41D12
 
D Back to top
daclizumab Approved drug Immunopharmacology Ligand 6880 L04AC01, RO-24-7375, Ro-247375, Zenapax®
dapirolizumab pegol Immunopharmacology Ligand 11123 CDP-7657, CDP7657, DZP
daratumumab Approved drug Immunopharmacology Ligand 7395 3003-005, Darzalex®, HuMax-CD38, JNJ-54767414
dectrekumab Immunopharmacology Ligand 8714 QAX-576, QAX576
demcizumab 8451 OMP-21M18, OMP21M18
denosumab Approved drug 6886 AMG-162, M05BX04, Prolia®, Xgeva®
depatuxizumab mafodotin 7970 ABT-414
dezamizumab 8255 GSK-2398852, GSK2398852
dinutuximab Approved drug 7979 APN-311, Ch14.18, MAb-14.18, Unituxin®
domagrozumab 9096 clone OGD1.0.0, PF-06252616, PF06252616
donanemab 8357
dostarlimab Approved drug 11518 ANB-011, dostarlimab-gxly, Jemperli®, TSR-042, WBP-285
dupilumab Approved drug Immunopharmacology Ligand 7574 Dupixent®, REGN668, SAR231893
durvalumab Approved drug Immunopharmacology Ligand 7985 anti-B7H1 monoclonal antibody, Imfinzi®, MEDI-4736, MEDI4736
dusigitumab 7749 MEDI-573
DX-2507 Immunopharmacology Ligand 9959
 
E Back to top
eculizumab Approved drug Immunopharmacology Ligand 6884 h5G1.1, h5G1.1VHC, Soliris®
edrecolomab Approved drug 7984 17-1A, PANOREX® (proposed trade name)
efalizumab Approved drug Immunopharmacology Ligand 6593 anti alphaL integrin, antiCD11 alpha, hu1124, Raptiva®
efgartigimod alfa Immunopharmacology Ligand 9777 ARGX-113
efineptakin alfa Immunopharmacology Ligand 11097 GX-I7, Hyleukin-7, Il-7 hybrid Fc, NT-I7, rhIL-7-hyFc, TJ-107
eldelumab Immunopharmacology Ligand 9047 BMS-936557, MDX-1100
elezanumab Immunopharmacology Ligand 9290 ABT-555, AE12-1Y-QL
elgemtumab 8715 LJM716, NVS201010
elotuzumab Approved drug Immunopharmacology Ligand 8361 BMS-901608, Empliciti®, HuLuc63
emactuzumab Immunopharmacology Ligand 8944 RG7155, RO5509554
emapalumab Approved drug Immunopharmacology Ligand 9295 emapalumab-lzsg, Gamifant®, NI-0501, NI0501
emibetuzumab 7748 LA480, LY-2875358, LY2875358
emicizumab Approved drug 9744 ACE-910, ACE910, emicizumab-kxwh, Hemlibra®, RG6013
enfortumab vedotin Approved drug 10738 ASG-22CE, enfortumab vedotin-ejfv, Padcev®
enoblituzumab Immunopharmacology Ligand 9589 MGA-271, MGA271
enokizumab Immunopharmacology Ligand 8934 7F3com-2H2, MEDI-528, MEDI528
envafolimab Immunopharmacology Ligand 10492 KN-035, KN035
epcoritamab Immunopharmacology Ligand 11442 GEN-3013, GEN3013
epratuzumab Immunopharmacology Ligand 8088 90Y-DOTA-hLL2, 90Y-epratuzumab tetraxetan, 90Y-hLL2, AMG-412, IMMU-hLL2, LymphoCide® (proposed proprietary name)
eptinezumab Approved drug 10694 ALD-403, ALD403, eptinezumab-jjmr, Vyepti®
erenumab Approved drug 9250 Aimovig®, AMG 334, AMG-334, erenumab-aooe
etanercept Approved drug Immunopharmacology Ligand 6789 Enbrel®, Rhu Tnfr:Fc, TNFR-Fc, TNR 001
etaracizumab 6596 etaratuzumab, hLM60, MEDI-522
etesevimab 11331 CB-6, JS-016, LY-CoV016, LY3832479
etrolizumab Immunopharmacology Ligand 8407 PRO145223, RG-7413, RG7413, rhuMAb Beta7
evinacumab Approved drug 8717 evinacumab-dgnb, Evkeeza®, REGN1500
evolocumab Approved drug 7343 AMG-145, AMG145, Repatha®
 
F Back to top
faricimab 11420 RG-7716, RG7716, RO-6867461, RO6867461
fasinumab 8965 REGN475, SAR164877
feladilimab 11649 GSK-3359609
fezakinumab Immunopharmacology Ligand 9281 ILV-094
fibatuzumab 8925 KB-004, KB004
fontolizumab Immunopharmacology Ligand 9847 HuZAF
fremanezumab Approved drug 9208 Ajovy®, fremanezumab-vfrm, LBR-101, PF-04427429, PF-4427429, RI-307, RN-307, RN307, TEV-48125
fresolimumab 8264 GC1008, PET1073G12
fulranumab 8964 AMG-403, JNJ-42160443
 
G Back to top
galcanezumab Approved drug Immunopharmacology Ligand 8967 clone III, Emgality®, galcanezumab-gnlm, LY-2951742, LY2951742
gantenerumab 6933 R-1450, RG-1450, Ro-4909832
gemtuzumab ozogamicin Approved drug Immunopharmacology Ligand 6775 CDP 771, CMA 676, hP67.6-calicheamicin, Mylotarg®, WAY-CMA 676
gevokizumab Immunopharmacology Ligand 7394 XOMA 052, XOMA-052
gimsilumab Immunopharmacology Ligand 9624 MORAb-022
girentuximab 7987 cG250, G250, Rencarex® (proposed proprietary name), WX-G250
glembatumumab vedotin 8926 CDX-011, CR011-vcMMAE
golimumab Approved drug Immunopharmacology Ligand 6776 CNTO-148, CNTO148, Simponi®
GSK3050002 Immunopharmacology Ligand 9623 E6071, KANAb071
guselkumab Approved drug Immunopharmacology Ligand 7998 CNTO-1959, Tremfya®
 
I Back to top
ianalumab Immunopharmacology Ligand 10656 VAY-736, VAY736
ibalizumab Approved drug Immunopharmacology Ligand 10208 Hu5A8, ibalizumab-uiyk, TMB-355, TMB355, TNX-355, Trogarzo®
ibritumomab tiuxetan Approved drug Immunopharmacology Ligand 6777 IDEC-2B8, IDEC-Y2B8-yttrium ibritumomab tiuxetan, NSC-715848, Zevalin®
idarucizumab Approved drug 8298 aDabi-Fab, BI 655075, Praxbind®
IGN523 8737
IMAB362 9209
imaprelimab Immunopharmacology Ligand 9805 PRX-003, PRX003
IMCgp100 Immunopharmacology Ligand 7378
imdevimab Approved drug 11328 REGN-10987, REGN10987, Ronapreve® (imdevimab + casirivimab)
inbakicept 11593 15RalphaSu-Fc
indusatumab vedotin 8718 5F9vcMMAE, MLN-0264, MLN0264, TAK-264, TAK264
inebilizumab Approved drug 7992 HB12, inebilizumab-cdon, MEDI 551, MEDI-551, MEDI551, Uplizna®
infliximab Approved drug Immunopharmacology Ligand 5004 cA2, Inflectra®, Remicade®, Remsima®, SB2, TA-650
inotuzumab ozogamicin Approved drug Immunopharmacology Ligand 8266 Besponsa®, CMC-544
ipafricept 10325 FZD8-Fc, OMP-54F28, OMP54F28
ipilimumab Approved drug Immunopharmacology Ligand 6888 MDX-010, MDX-101, MDX-CTLA-4, Yervoy®
isatuximab Approved drug 8719 ch38SB19, hu38SB19, isatuximab-irfc, SAR-650984, SAR650984, Sarclisa®
istiratumab 8930 MM-141, MM141
itolizumab Approved drug Immunopharmacology Ligand 9421 Alzumab®, T1h
ixekizumab Approved drug Immunopharmacology Ligand 7541 LY-2439821, LY2439821, Taltz®
 
L Back to top
labetuzumab 8251 CEACIDE®, hMN14
labetuzumab govitecan 8252 hMN-14-SN-38, hMN-14-SN-38 ADC, IMMU 130, IMMU-130
lampalizumab 8294 anti-factor D, FCFD4514S, RG7417
lanadelumab Approved drug 9094 DX-2930, lanadelumab-flyo, Takhzyro®, X124-G01
landogrozumab 8730 LY-2495655, LY2495655
lebrikizumab Immunopharmacology Ligand 7684 MILR1444A, RG3637, TNX-650
lenzilumab Immunopharmacology Ligand 8935 KB-003, KB003
leronlimab Immunopharmacology Ligand 10752 PRO 140, PRO-140, PRO140, Vyrologix®
lifastuzumab vedotin 8405 DNIB0600A, RG-7599, RG7599
ligelizumab Immunopharmacology Ligand 8997 CL-2C, NVP-QGE031, QGE031
lilotomab Immunopharmacology Ligand 9950 Betalutin®, HH1, tetulomab
lintuzumab Immunopharmacology Ligand 7983 ACTIMAB®, HuM195, SGN-33, SMART M195
lirilumab Immunopharmacology Ligand 9310 1-7F9, BMS-986015, IPH2102
loncastuximab tesirine Approved drug 11521 ADCT-402, ADCT402, loncastuximab tesirine-lpyl, RB4v1.2-SG-3249, Zynlonta®
lorvotuzumab mertansine 7431 BB-10901, IMGN901
lulizumab pegol Immunopharmacology Ligand 8460 BMS-931699, BMS931699
luspatercept Approved drug 10538 ACE-536, ACE536, luspatercept-aamt, Reblozyl®
lutikizumab Immunopharmacology Ligand 9297 ABT-981, E26.13-SS-X3
LY2928057 8416
LY3022855 Immunopharmacology Ligand 9109 IMC-CS4
 
M Back to top
MAB92 Immunopharmacology Ligand 9665
mAb 4A8 11079
margetuximab Approved drug 8686 Margenza®, margetuximab-cmkb, MGAH-22
mavrilimumab Immunopharmacology Ligand 7785 CAM-3001, KPL-301
MCS110 Immunopharmacology Ligand 9110
meplazumab Antimalarial Ligand 11026 HP6H8, Ketantin®
mepolizumab Approved drug Immunopharmacology Ligand 7685 Nucala®, SB-240563
mezagitamab Immunopharmacology Ligand 10609 TAK-079, TAK079
milatuzumab Immunopharmacology Ligand 8267 hLL1, IMMU-115
mirikizumab Immunopharmacology Ligand 9846 Antibody I [US9023358], LY-3074828, LY3074828
mitumomab 7981 monoclonal antibody BEC2
MM-111 8931
MM-151 9125
mogamulizumab Approved drug Immunopharmacology Ligand 6477 KW-0761, mogamulizumab-kpkc, Poteligeo®
monalizumab Immunopharmacology Ligand 8323 humZ270, IPH-2201, NN8765-3658
moxetumomab pasudotox Approved drug Immunopharmacology Ligand 7675 CAT-8015, GCR-8015, HA22, Lumoxiti®, moxetumomab pasudotox-tdfk
muromonab-CD3 Approved drug Immunopharmacology Ligand 6889 L04AA02, OKT-3, Orthoclone Okt3®
 
N Back to top
namilumab Immunopharmacology Ligand 10370 AMG203, MT203
naptumomab estafenatox Immunopharmacology Ligand 9948 ABR-217620, ABR217620, Anyara (proposed trade name), TTS CD3, TTS-CD3
naratuximab emtansine Immunopharmacology Ligand 9949 IMGN-529, IMGN529, K7153A-SMCC-DM1
natalizumab Approved drug Immunopharmacology Ligand 6591 AN100226, anti-alpha4 integrin, anti-VLA4, Tysabri®
naxitamab Approved drug 11341 DANYELZA®, hu3F8, naxitamab-gqgk
necitumumab Approved drug 8090 11F8, IMC-11F8, LY3012211, Portrazza®
nemolizumab Immunopharmacology Ligand 8720 CD14152, CIM 331, CIM331
nesvacumab 8457 REGN-910, REGN910, SAR307746
nimotuzumab Approved drug 7988 h-R3, THERACIM®, Theraloc®
nivolumab Approved drug Immunopharmacology Ligand 7335 BMS-936558, MDX-1106, ONO-4538, Opdivo®
 
O Back to top
obinutuzumab Approved drug Immunopharmacology Ligand 6941 GA-101, GA101, Gazyva®
ocrelizumab Approved drug Immunopharmacology Ligand 7580 2H7, Ocrevus®, PRO70769, RG1594
ofatumumab Approved drug Immunopharmacology Ligand 6778 Arzerra®, GSK 1841157, GSK1841157, humax-CD20, Kesimpta® (subcutaneous), OMB-157, OMB157
olaratumab Approved drug 9172 IMC-3G3, Lartruvo®, LY3012207
oleclumab Immunopharmacology Ligand 9596 MEDI 9447, MEDI-9447
olokizumab 11601 CDP 6038, CDP-6038, CDP6038
omalizumab Approved drug Immunopharmacology Ligand 6890 IGE25, olizumab, R03DX05, RG-3648, rhumab-E25, Xolair®
onartuzumab 8966 MetMAb, OA-5D5, OA5D5, PRO 143966
onfekafusp alfa Immunopharmacology Ligand 9757 Fibromun
ontamalimab Immunopharmacology Ligand 9340 PF-00547659, PF-547659, SHP647
opicinumab 8923 BIIB-033, BIIB033
OSE-127 Immunopharmacology Ligand 9604 Effi-7
osocimab 11366 BAY 1213790, BAY-1213790, BAY1213790
otelixizumab 8458 ChAglyCD3, TRX4
otilimab Immunopharmacology Ligand 11132 GSK-3196165, GSK3196165, MOR-103, MOR103
otlertuzumab Immunopharmacology Ligand 9951 CD37-SMIP, TRU-016, TRU016
ozanezumab 8254 GSK-1223249, GSK1223249
ozoralizumab Immunopharmacology Ligand 9638 ATN-103, PF-5230896
 
P Back to top
pamrevlumab 8928 FG-3019
panitumumab Approved drug 6883 ABX-EGF, ABX-EGF Mab, Vectibix®
pascolizumab Immunopharmacology Ligand 7786 SB-240683
pateclizumab Immunopharmacology Ligand 9854 MLTA3698A, PRO283698, RG7416
pembrolizumab Approved drug Immunopharmacology Ligand 7499 Keytruda®, lambrolizumab, MK-3475
pemtumomab 8031 HMFG1, HuHMFG-1
pepinemab 8932 mAb 62-7, VX15/2503
pertuzumab Approved drug 5046 2C4, Omnitarg® (obsolete trade name), Perjeta®
PF-07062119 11125
pidilizumab 7692 BAT mAb, CT-011, MDV9300
PiN-21 11551 Pittsburgh inhalable Nanobody 21
plonmarlimab Immunopharmacology Ligand 11644 TJ 003234, TJ003234, TJM2
plozalizumab Immunopharmacology Ligand 8921 hu1D9, MLN-1202, MLN1202
polatuzumab vedotin Approved drug Immunopharmacology Ligand 8404 ACD79B-VCMMAE, polatuzumab vedotin-piiq, Polivy®, RG-7596, RG7596, RO5541077-000
 
Q Back to top
quilizumab Immunopharmacology Ligand 8998 47H4 v5 hulgG1, MEMP1972A, RG-7449
 
R Back to top
racotumomab Approved drug 7995 1E10, Vaxira®
ramucirumab Approved drug 7390 Cyramza®, IMC-1121B
ranibizumab Approved drug 6779 Fab-12 variant Y0317, Lucentis®, muMAb VEGF A.4.6.1, rhuFab V2
ravulizumab Approved drug Immunopharmacology Ligand 10168 ALXN-1210, ALXN1210, ravulizumab-cwvz, Ultomiris®
regdanvimab 11332 CT-P-59, CT-P59
relatlimab Immunopharmacology Ligand 9536 BMS-986016, BMS986016, ONO-4482
remtolumab Immunopharmacology Ligand 9597 A-1230717, ABT-122
reslizumab Approved drug Immunopharmacology Ligand 8091 CDP-835, CDP835, Cinqaero®, Cinqair®, JES1-39D10, SCH55700
retifanlimab 11583 hPD-1 mAb 7(1.2), INCMGA0012, MGA012
rilonacept Approved drug Immunopharmacology Ligand 6790 Arcalyst®, IL-1 Trap, interleukin-1 Trap
rilotumumab 7986 AMG 102, AMG102
risankizumab Approved drug Immunopharmacology Ligand 8922 ABBV-066, BI 655066, BI-655066, risankizumab-rzaa, Skyrizi®
rituximab Approved drug Immunopharmacology Ligand 6780 HSDB 7455, IDEC-C2B8, MabThera®, Rituxan®
romosozumab Approved drug 8092 AMG-785, CDP-7851, Evenity®, romosozumab-aqqg
rontalizumab Immunopharmacology Ligand 9640 9F3v13, RhuMAB IFNalpha, rhuMAb interferon-α
rovalpituzumab tesirine 10561 Rova-T, SC0001-SCX
rovelizumab Immunopharmacology Ligand 9598 Hu23F2G, LeukArrest
rozanolixizumab